Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

15.4K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.4K
Blood Transfusion01:15

Blood Transfusion

2.9K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.9K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rezvilutamide in combination with androgen deprivation therapy (ADT) with or without docetaxel in the neoadjuvant treatment of oligometastatic prostate cancer (REDOOM): study protocol for an open-label, parallel-cohort, multicentre clinical study.

BMJ open·2026
Same author

Notoginsenoside-Fa mitigates vascular endothelial permeability via targeting SUGT1 to stabilize NLRP3 in a resting state.

British journal of pharmacology·2026
Same author

<i>Alfaria yunnanensis</i> sp. nov., a novel myrothecium-like species isolated from <i>Oryza sativa</i> in Yunnan, China.

International journal of systematic and evolutionary microbiology·2026
Same author

Effects of Preparation Methods on the Structure and Mechanical Properties of Kyanite-Reinforced Alumina Ceramics.

Nanomaterials (Basel, Switzerland)·2026
Same author

Tracking Nanofertilizer (Au@mZnO-mSiO<sub>2</sub>) Uptake and Transportation in Cucumber Simultaneously by LA-ICP-MS and ICP-MS.

Journal of agricultural and food chemistry·2026
Same author

Correlation analysis of fundamental movement skills level and aquatic competence acquisition in children aged 4-6 years.

Frontiers in public health·2026

Related Experiment Video

Updated: Mar 19, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

20.6K

[CD36 Antigen Deficiency and Platelet Transfusion].

Hai-Yan Li1, Yan Zhou1, Wei-Dong Shen1

  • 1Nanning Institute of Transfusion Medicine, Nanning Blood Center, Nanning 530007, Guangxi Province, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|June 26, 2016
PubMed
Summary

CD36 deficiency can lead to anti-CD36 antibodies, causing issues like refractoriness in immune platelet transfusions. This review covers CD36 deficiency, its molecular basis, and antibody detection methods.

More Related Videos

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation
06:57

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation

Published on: May 20, 2021

4.6K
Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.6K

Related Experiment Videos

Last Updated: Mar 19, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

20.6K
Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation
06:57

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation

Published on: May 20, 2021

4.6K
Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.6K

Area of Science:

  • Immunology
  • Hematology
  • Molecular Biology

Background:

  • CD36 is a multi-ligand receptor glycoprotein with diverse biological roles.
  • CD36 deficiency can arise from various triggers, including blood transfusion, pregnancy, and organ transplantation.
  • The presence of anti-CD36 antibodies is linked to adverse clinical outcomes.

Purpose of the Study:

  • To review recent advances in understanding CD36 deficiency.
  • To explore the molecular biological basis of CD36 deficiency.
  • To summarize current knowledge on platelet transfusion and CD36 antibody detection.

Main Methods:

  • Literature review of recent research on CD36 deficiency.
  • Analysis of molecular mechanisms underlying CD36 deficiency.
  • Synthesis of information on CD36 antibody detection techniques.

Main Results:

  • CD36 deficiency can trigger alloimmune antibody production.
  • These antibodies contribute to transfusion refractoriness and other immune-related diseases.
  • Advances in understanding CD36's role and detection methods are highlighted.

Conclusions:

  • CD36 deficiency presents significant clinical challenges, particularly in transfusion medicine.
  • Further research into CD36's molecular basis and antibody detection is crucial.
  • Improved diagnostic and therapeutic strategies are needed for patients with CD36-related conditions.